Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina

Canadian Journal of Cardiology

Volumn 15, Issue 10, 1999, Pages 1103-1109

  Toal, Corey B ^a,n   Michael Motro, Md ^b   Baird, Michael G ^c   Klinke, Peter ^d   Sclarowski, Samuel ^e   Zilberman, Avraham ^f   Marmor, Alon ^g   Kostuk, William J ^h   Lotan, Chaim ⁱ   Weiss, Avraham ⁱ   Erne, Paul ^j   Palant, Avraham ^k   Stolero, Dan ^o   Bélanger, Laurent ^l   Turpie, Alexander ^m  

^a UNIVERSITY OF TORONTO   (Canada)

^b SHEBA MEDICAL CENTER   (Israel)

^c UNIVERSITY OF OTTAWA   (Canada)

^d ROYAL JUBILEE HOSPITAL   (Canada)

^e RABIN MEDICAL CENTER   (Israel)

^f BIKUR CHOLIM HOSPITAL   (Israel)

^g Oral and Maxillofacial Unit   (Israel)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^j LUZERNER KANTONSSPITAL   (Switzerland)

^k Hakarmel Hospital   (Israel)

^l INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^m MCMASTER UNIVERSITY   (Canada)

ⁿ Bayer Inc   (Canada)

^o Bayer Inc ^*

more..

Author keywords

Angina; Beta blockers; Calcium channel blockers; Clinical trials; Drugs

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE GITS; NITRATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDEMA; FEMALE; GASTROINTESTINAL THERAPEUTIC SYSTEM; HEADACHE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGINA PECTORIS; ATENOLOL; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; VASODILATOR AGENTS;

EID: 0343415559     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ekelund L-G, Orö L. Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind randomized subacute study. Clin Cardiol 1979;2:203-11.
2. Lynch P, Dargie H, Krikler S, Krikler D. Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. BMJ 1980;281:184-7.
3. Findlay IN, MacLeod K, Ford M, Gillen G, Elliott AT, Dargie HJ. Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Br Heart J 1986;55:240-5.
4. Chung M, Reitberg DP, Gaffney M, Singleton W. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. Am J Med 1987;83(Suppl 6B):10-4.
5. Vetrovec GW. Once daily therapy for angina pectoris with nifedipine gastrointestinal therapeutic system. Am J Med 1989;86(Suppl 1A): 28-32.
6. Bittar N. Usefulness of nifedipine for myocardial ischemia and the nifedipine gastrointestinal therapeutic system. Am J Cardiol 1989;64:31F-4F.
7. Parmley WW, Nesto RW, Singh BN, Deanfield J, Gottlieb SO and the N-CAP study group. Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 1992;19:1380-9.
8. Siu SC, Jacoby RM, Phillips RT, Nesto RW. Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris. Am J Cardiol 1993;71:887-92.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stats Assoc 1958;53:457-81.
10. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons, 1980.
11. Bélanger LG, Charbonneau M, Lavallée J-P, Lenis J, Ouellet AC. Treatment of stable angina pectoris with calcium antagonists alone or combined with beta-blocking agents: A review of the literature. Can J Cardiol 1986;2:212-7.
12. Challenor VF, Waller DG, George CF. Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris. Cardiovasc Drugs Ther 1989;3:275-85.
13. Packer M. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Engl J Med 1989;320:709-18.
14. Fox K, Mulcahy D, Findlay I, Ford I, Dargie H on behalf of the TIBET study group. The total ischaemic burden European trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. Eur Heart J 1996:17:96-103.
15. Stone PH, Turi ZG, Muller JE. Efficacy of nifedipine therapy for refractory angina pectoris. Am Heart J 1982;104:672-80.
16. Young KD, Macdonald G. Treatment of angina pectoris in general practice with a combination of nifedipine and beta-blocker. Br J Clin Pract 1982;36:103-10.
17. deVries RJM, van den Heuvel AFM, Lok DJA, et al, for the Netherlands Working Group on Cardiovascular Research (WCN). Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. Int J Cardiol 1996;57:143-50.
18. Tweddel AC, Beattie JM, Murray RG, Huton I. The combination of nifedipine and propranolol in the management of patients with angina pectoris. Br J Clin Pharmacol 1981;12:229-33.
19. Mohiuddin SM, Hilleman DE. Substituting nifedipine-GITS for immediate-release calcium-channel antagonist in patients with stable angina pectoris. Curr Ther Res 1991;50:546-52.